참고문헌
- Feigelson, H. S. and Henderson, B. E. (1996) Estrogens and breast cancer. Carcinogenesis 17, 2279-2284. https://doi.org/10.1093/carcin/17.11.2279
- Helzlsouer, K. J.. Selmin, O., Huang, H. Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Watson, M., Comstock, G. W. and Bell, D. (1998) Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90, 513-518.
- Kang, H. J., Kim, S. W., Ahn, S. J., Bae. J. Y., Park, S. K., Kang, D., Hirvonen, A., Choe, K. J. and Noh, D. Y. (2002) Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Lett. 178, 175-180. https://doi.org/10.1016/S0304-3835(01)00861-8
- Kim, S. U., Park, S. K., Yoo, K. Y., Yoon, K. S., Choi, J. Y., Noh, D. Y., Ahn, S. H., Choe, K. J., Strickland, P. T., Hirvonen, A and Kang, D. (2002) XRCC1 genetic polymorphism and breast cancer risk. Phamlacogenetics 12, 335-338. https://doi.org/10.1097/00008571-200206000-00010
- Park, S. K., Yoo, K. Y., Lee, S. J., Kim, S. U., Ahn, S. H., Noh, D. Y., Choe, K. J., Strickland, P. T., Hirvonen, A and Kang D. (2000) Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Phamwcogenetics 10, 1-9. https://doi.org/10.1097/00008571-200002000-00001
- Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L., Young, J. (1997) Cancer Incidence in Five Continents, Vol VII, International Agency for Research on Cancer (IARC). Scientific Publications No. 143, Lyon.
- Shen, M. R., Jones, I. M. and Mohrenweiser, H. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA genes in healthy humans. Cancer Res. 58, 604-608.
- Yager, J. D. and Liehr, J. G. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacal. Toxieol. 36, 203-232 https://doi.org/10.1146/annurev.pa.36.040196.001223
-
Yim, D. S., Park, S. K., Yoo, K. Y., Yoon, K. S., Chung, H. H., Ahn, S. H., Noh, D. Y, Choe, K. J., Jang, I. J., Shin, S. G., Strickland, P. T., Hirvonen, A. and Kang D. (2001) Relationship between the
$Val^{158}$ Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 11, 279-286. https://doi.org/10.1097/00008571-200106000-00001 - Yoo, K. Y., Kang, D., Park, S. K., Kim, S. D., Shin, A. S., Yoon, H., Ahn, S. H., Noh, D. Y. and Choe, K. J. (2002) Epidemiology of breast cancer in Korea. Occurrence, high risk groups, and prevention. J. Korean Med. Sci. 17, 386-390
- Yu, Z., Chen, J., Ford, B. N., Brackley, M. E. and Glickman, B. W. (1999) Human DNA repair systems: an overview. Environ. Mol. Mutag. 33, 3-20. https://doi.org/10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L
- Zhu, B. T. and Conney, A. H. (1998) Functional role of estrogen metabolism in target cells; review and perspectives. Carcinogenesis 12, 1-27.
피인용 문헌
- SNP-SNP interactions in breast cancer susceptibility vol.6, pp.1, 2006, https://doi.org/10.1186/1471-2407-6-114
- Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis vol.7, pp.1, 2012, https://doi.org/10.1186/1746-1596-7-136
- Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis vol.122, pp.2, 2010, https://doi.org/10.1007/s10549-009-0694-5
- Induction of CYP1A1 and CYP1B1 and formation of carcinogen–DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene vol.221, pp.2, 2005, https://doi.org/10.1016/j.canlet.2004.08.038
- Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: A meta-analysis involving 16,703 individuals vol.56, pp.2, 2011, https://doi.org/10.1016/j.cyto.2011.06.018
- Genetic Polymorphism of XRCC1 Correlated with Response to Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer vol.18, pp.4, 2012, https://doi.org/10.1007/s12253-012-9536-6
- Breast Cancer Screening for Korean Women Must Consider Traditional Risks as well as Two Genetic Risk Factors vol.30, pp.3, 2007, https://doi.org/10.1097/01.NCC.0000270705.41919.dc
- Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population vol.69, pp.4, 2011, https://doi.org/10.1016/j.maturitas.2011.05.008
- Current researches on breast cancer epidemiology in Korea vol.10, pp.4, 2003, https://doi.org/10.1007/BF02967647
- Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women vol.141, pp.4, 2015, https://doi.org/10.1007/s00432-014-1849-2
- Possible Risk Modification by Polymorphisms of Estrogen Metabolizing Genes in Familial Breast Cancer Susceptibility in an Indian Population vol.28, pp.3, 2010, https://doi.org/10.3109/07357900902744494
- Gene polymorphisms in bladder cancer vol.26, pp.1, 2008, https://doi.org/10.1016/j.urolonc.2006.10.011
- CYP1A1 and GSTM1/T1 Genetic Variation in Predicting Risk for Cerebral Infarction vol.32, pp.2, 2007, https://doi.org/10.1007/s12031-007-0028-1
- Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures vol.124, pp.3, 2010, https://doi.org/10.1007/s10549-010-0895-y
- Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy 2018, https://doi.org/10.1002/jcp.25966
- Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario vol.5, pp.1, 2007, https://doi.org/10.1186/1741-7015-5-22
- The Polymorphism of DNA Repair Gene ERCC2/XPD Arg156Arg and Susceptibility to Breast Cancer in a Chinese Population vol.47, pp.7-8, 2009, https://doi.org/10.1007/s10528-009-9246-2
- Influence of the CYP17 polymorphism on vasomotor symptoms in postmenopausal women: a pilot study vol.14, pp.5, 2011, https://doi.org/10.3109/13697137.2010.548668
- RETRACTED: Genetic Polymorphism of XRCC1 Correlated with Response to Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer vol.31, pp.1, 2013, https://doi.org/10.3109/07357907.2012.716468
- Genetic losses in breast cancer: toward an integrated molecular cytogenetic map vol.160, pp.2, 2005, https://doi.org/10.1016/j.cancergencyto.2004.12.018
- Estrogen Receptor α Gene Polymorphism and Breast Cancer vol.1138, pp.1, 2008, https://doi.org/10.1196/annals.1414.015
- Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis vol.122, pp.2, 2010, https://doi.org/10.1007/s10549-009-0728-z
- Polymorphisms of the DNA polymerase β gene in breast cancer vol.103, pp.2, 2007, https://doi.org/10.1007/s10549-006-9357-y
- Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results From the Breast Cancer Association Consortium vol.98, pp.19, 2006, https://doi.org/10.1093/jnci/djj374
- XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis vol.121, pp.2, 2010, https://doi.org/10.1007/s10549-009-0562-3